Cargando…
Efficacy of Replacement and Anti-Platelet Therapies in a Patient with Severe Haemophilia A Undergoing Percutaneous Coronary Stent Implantation
INTRODUCTION: Severe haemophilia A is characterized by serious factor VIII deficiency (biological activity <1%) resulting in frequent spontaneous haemorrhage and abnormal bleeding after minor injury, surgery or tooth extraction. PATIENT AND METHODS: We report the case of a 58-year-old patient wit...
Autores principales: | Cultrera, Dorina, Cabibbo, Sergio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9426961/ https://www.ncbi.nlm.nih.gov/pubmed/36051165 http://dx.doi.org/10.12890/2022_003343 |
Ejemplares similares
-
The platelet-to-lymphocyte ratio as a predictor of all-cause mortality in patients with coronary artery disease undergoing elective percutaneous coronary intervention and stent implantation
por: Osadnik, Tadeusz, et al.
Publicado: (2015) -
Primary Percutaneous Coronary Intervention in a Patient with Haemophilia A
por: Reddy, S. Ashwin, et al.
Publicado: (2013) -
Efficacy of Triple Anti-Platelet Therapy Including Cilostazol in Acute Myocardial Infarction Patients Undergoing Drug-Eluting Stent Implantation
por: Park, Keun-Ho, et al.
Publicado: (2009) -
The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019) -
Factors Affecting In-stent Restenosis in Patients Undergoing Percutaneous Coronary Angioplasty
por: Sajadian, Mostafa, et al.
Publicado: (2018)